Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...

To design the vaccines of the future ... RNA viruses, such as HIV, are an extreme example of how in the absence of proof-editing of the genetic code a virus can generate antigenically different ...

Vaccitech's six products are all in early stage trials or pre-clinical testing, and are all based on the viral vector vaccine technology. The vaccines can be used as treatment or prophylaxis ...

Another hemorrhagic threat is Lassa Fever, a virus in West Africa infecting between 100,000 and 300,000 people annually, ...

Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Q4 2024 Results Conference Call March 4, 2025 4:30 AM ET Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer ...

Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...

The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Cornell University researchers used a new technology to design a vaccine that they say provides full protection against both ...

The standard protective dose is almost 14,000 units, but even 500 units raises antibody levels sufficiently to do the job.

The vaccine is the only way to prevent measles, but it also prevents other illnesses. The other "M" stands for mumps, and the ...

Experts debate whether European manufacturers are preferring domestic operations as the continent competes with Asia and the ...